Pfizer-BioNTech Submit Data on Pediatric Vaccines to FDA: What to Know
Pfizer and BioNTech announced today that they have submitted initial data to the Food and Drug Administration from their COVID-19 vaccine trial in children ages 5 to 11.
Pfizer and BioNTech announced today that they have submitted initial data to the Food and Drug Administration from their COVID-19 vaccine trial in children ages 5 to 11.
No comments:
Post a Comment